Jia Zhou

12.7k total citations · 4 hit papers
278 papers, 9.3k citations indexed

About

Jia Zhou is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jia Zhou has authored 278 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Molecular Biology, 49 papers in Oncology and 36 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jia Zhou's work include Receptor Mechanisms and Signaling (34 papers), Protein Degradation and Inhibitors (29 papers) and Bioactive Natural Diterpenoids Research (18 papers). Jia Zhou is often cited by papers focused on Receptor Mechanisms and Signaling (34 papers), Protein Degradation and Inhibitors (29 papers) and Bioactive Natural Diterpenoids Research (18 papers). Jia Zhou collaborates with scholars based in United States, China and Spain. Jia Zhou's co-authors include Haiying Chen, Eric A. Wold, Na Ye, Haijun Chen, Qiang Shen, Zhiqing Liu, Pei‐Yong Shi, Jimin Xu, Ye Ding and Chunyong Ding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jia Zhou

265 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity

2020 734 citations Wenjing Yang, Tianming Yu et al. Nature Communications profile →
Therapeutic Potential of Spirooxindoles as Antiviral Agents

2016 412 citations Na Ye, Haiying Chen et al. profile →
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

2024 56 citations Wei Wang, Najah Albadari et al. Pharmacological Reviews profile →
FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production

2024 42 citations Jia Zhou, Chuang Peng et al. profile →

Peers

Countries citing papers authored by Jia Zhou

Since Specialization

Citations

This map shows the geographic impact of Jia Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Zhou more than expected).

Fields of papers citing papers by Jia Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Zhou. The network helps show where Jia Zhou may publish in the future.

Co-authorship network of co-authors of Jia Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Zhou. A scholar is included among the top collaborators of Jia Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Zhou. Jia Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge 2025 ·Antiviral Research ·(unknown), Jun Li, (unknown), Hamid Soraya, Jimin Xu, Haiying Chen, (unknown), Jerónimo Pachón, (unknown), Jia Zhou, (unknown)	2
2	YX0798 is a highly potent, selective, and orally effective CDK9 inhibitor for treating aggressive lymphoma 2025 ·Blood Advances ·Changying Jiang, (unknown), (unknown), Qingsong Cai, (unknown), (unknown), (unknown), Yang Liu, Haiying Chen, Jia Zhou, Michael Wang	0
3	A New Era of Artificial Intelligence (AI): Transforming Drug Discovery and Development 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Haiying Chen, Jia Zhou	1
4	Integration of Meta-Analysis and Network Pharmacology to Investigate the Pharmacological Mechanisms of Quercetin on Hepatocellular Carcinoma 2025 ·Frontiers in Bioscience-Landmark ·(unknown), (unknown), (unknown), You Tang, Bo Sun, Jia Zhou, Yufan Zhou, Ou Li, Chuang Peng, (unknown)	0
5	MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future breakdown → 2024 ·Pharmacological Reviews ·Wei Wang, Najah Albadari, (unknown), (unknown), (unknown), Wa Xian, Frank McKeon, Wěi Li, Jia Zhou, Ruiwen Zhang	56
6	Orphan GPR52 as an emerging neurotherapeutic target 2024 ·Drug Discovery Today ·(unknown), Pingyuan Wang, (unknown), John Allen, Jia Zhou	9
7	RIPTACs: A groundbreaking approach to drug discovery 2023 ·Drug Discovery Today ·Zonghui Ma, (unknown), Jia Zhou	14
8	Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022) 2023 ·European Journal of Medicinal Chemistry ·(unknown), Jia Zhou	70
9	BRD4 as a potential target for human papillomaviruses associated cancer 2023 ·Journal of Medical Virology ·(unknown), Srinivasa Reddy Bonam, Jia Zhou, (unknown), Haitao Hu, Xuefeng Liu	1
10	Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment 2021 ·Current Topics in Medicinal Chemistry ·(unknown), Jianping Chen, Jia Zhou, Daqing Wu	5
11	Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors 2021 ·European Journal of Medicinal Chemistry ·Pingyuan Wang, Dharini van der Hoeven, Na Ye, Haiying Chen, Zhiqing Liu, Xiaoping Ma, Dina Montufar‐Solis, (unknown), Kwang‐Jin Cho, (unknown), Wei Chen, Ransome van der Hoeven, Jeffrey A. Frost, John F. Hancock, Jia Zhou	8
12	Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer 2021 ·European Journal of Medicinal Chemistry ·Gang Liu, Hye‐Jin Kim, Pingyuan Wang, (unknown), Haiying Chen, Tianzhi Wang, Qiang Shen, Jia Zhou	8
13	Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome 2021 ·International Journal of Molecular Sciences ·Jimin Xu, Judith Berastegui‐Cabrera, Marta Carretero-Ledesma, Haiying Chen, Yu Xue, Eric A. Wold, Jerónimo Pachón, Jia Zhou, Javier Sánchez‐Céspedes	7
14	Molecular targeting therapies for neuroblastoma: Progress and challenges 2020 ·Medicinal Research Reviews ·Atif Zafar, Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon, Jennifer H. Foster, Jia Zhou, Ruiwen Zhang	229
15	Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity breakdown → 2020 ·Nature Communications ·Wenjing Yang, Tianming Yu, Xiangsheng Huang, Anthony J. Bilotta, Leiqi Xu, Yao Lu, Jiaren Sun, Fan Pan, Jia Zhou, Wenbo Zhang, Suxia Yao, Craig L. Maynard, Nagendra Singh, Sara M. Dann, Zhanju Liu, Yingzi Cong	734
16	Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer 2018 ·European Journal of Medicinal Chemistry ·Yuqi Lin, Rong Liu, Ping Zhao, Jinxiang Ye, Zheng Zheng, (unknown), Yingying Zhang, Yu Gao, Haiying Chen, (unknown), Suling Liu, Jia Zhou, Ceshi Chen, Haijun Chen	14
17	Research Progress of the Mechanism of Combined Acupuncture-medication Anesthesia in Protecting Internal Organs During Perioperative Period of Pneumonectomy 2016 ·(unknown), Jia Zhou	0
18	A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5 2016 ·Cancer Letters ·Jing Wu, Ye Ding, (unknown), (unknown), Zhongmei Zhou, Chunyong Ding, Haiying Chen, Jia Zhou, Ceshi Chen	51
19	Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis 2015 ·Journal of Surgical Research ·Fredrick J. Bohanon, Xiaofu Wang, Brittany Graham, Chunyong Ding, Ye Ding, (unknown), Cristiana Rastellini, Jia Zhou, Ravi S. Radhakrishnan	25
20	Ribosomal proteins Rpl10 and Rps6 are potent regulators of yeast replicative life span 2006 ·Experimental Gerontology ·Andreas G. Chiocchetti, Jia Zhou, (unknown), Thomas Karl, (unknown), Mark Rinnerthaler, Gino Heeren, (unknown), Johann Bauer, Helmut Hintner, Michael Breitenbach, Hannelore Breitenbach‐Koller	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact